Bringing Evidence into Practice: Psoriasis Management in the Age of Newer Biologics

Release Date: April 20, 2017
Last Reviewed: January 16, 2017
Expiration Date: April 21 2018
Time to Complete Activity: 1.25 hours
*This activity expired for credit on April 21, 2018 and is no longer available for credit
 
Faculty
Gary Goldenberg, MD
Assistant Clinical Professor of Dermatology
Icahn School of Medicine at Mount Sinai Hospital
New York, NY
 
Linda Stein Gold, MD
Director of Clinical Research
Department of Dermatology
Henry Ford Hospital
Detroit, MI

Acknowledgement
This activity is provided by University of Kentucky College of Medicine. Paradigm Medical Communications, LLC, is the educational partner. 
  
 
 
Target Audience
This activity has been designed to address the educational needs of physicians specializing in dermatology. It will also benefit dermatology nurse practitioners, and PAs, as well as primary care clinicians (internal medicine and family practice) who manage patients with psoriasis.
 
Learning Objectives
Upon proper completion of this activity, participants should be better able to:
  • Review the clinical guideline recommendations for earlier, aggressive treatment of moderate to severe plaque psoriasis as a systemic disease with systemic agents and/or biologic drugs.
  • Explain newer pathways for the development of plaque psoriasis and their implications for determining treatment, based on current evidence.
  • Summarize the most current evidence for newer therapies, which will guide patient selection, treatment goals, and response monitoring in patients with psoriasis.
 
TABLE OF CONTENTS
Chapter 1: Introduction
Chapter 2: AAD Guideline Update
Chapter 3: Signaling Pathways in Psoriatic Disease
Chapter 4: New Therapies: Current and Ongoing Late-Phase Trial Data
Chapter 5: Faces of Psoriasis
 
Physician Accreditation Statement
The University of Kentucky College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 
The University of Kentucky College of Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
 
The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.
 
ACGME Competencies
  • Patient care, Medical knowledge, and Practice-based learning and improvement
The University of Kentucky is an Equal Opportunity University.

PA Continuing Education
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.25 Category 1 credits for completing this activity.
 
Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.  Individuals are responsible for checking with the AANPCP for further guidelines.
 
Disclosure of Commercial Support
This activity is supported by an unrestricted educational grant from Novartis Pharmaceuticals Corporation.
 
Get Credit Instructions
To receive a CME certificate of participation, you should:
  1. Follow instructions to register or log in with your professional information and complete the pre-activity assessment
  2. View the online activity in its entirety.
  3. After viewing the activity, go to Click Here to Get Credit
  4. If you are not signed into CECentral.com, you will either need to login or create an account (free of charge)
  5. Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the posttest.
  6. Your certificate will display; you can print it or view it later by clicking ‘Transcript’ in the blue bar at the top of the page
If you need assistance obtaining your certificate, please call (859) 257-5320, Monday–Friday, from 8:30 AM–4:30 PM ET.

For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.

There is no fee required for participation in this activity
 
Hardware/Software Requirements
This certified CME activity is designed using HTML5 audio.
 
Supported Browsers:
For Desktops (Windows/Mac)
Internet Explorer 9 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher
 
For Tablets (iPad/Android/Surface)
iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher
 
Technical Support: If you have any technical problems or playback issues email us at contactus@paradigmmc.com.
 
Disclosures
In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.
 
Faculty
Gary Goldenberg, MD
Retained Consultant: AbbVie Inc.; Celgene Corporation; Eli Lilly and Company; Novartis Pharmaceuticals Corporation;
Valeant Pharmaceuticals International, Inc.
Speakers Bureau: AbbVie Inc.; Celgene Corporation; Eli Lilly and Company; Novartis Pharmaceuticals Corporation
Honoraria: Valeant Pharmaceuticals International, Inc
 
Linda Stein Gold, MD
Grant/Research Support: Celgene Corporation; LEO Pharma Inc.; Pfizer Inc.
Retained Consultant: Celgene Corporation; LEO Pharma Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Promius Pharma, LLC.; Taro Pharmaceutical Industries Ltd.
Speakers Bureau: Celgene Corporation; LEO Pharma Inc.; Novartis Pharmaceuticals Corporation; Taro Pharmaceutical Industries Ltd.

Paradigm Medical Communications, LLC, staff members have no financial relationships to disclose.

University of Kentucky staff members have no financial relationships to disclose.
 
Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Resolution of Conflict of Interest
University of Kentucky College of Medicine and Paradigm Medical Communications, LLC, have implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, independent, fairly balanced, and aligned with the public interest. Conflicts, if any, are resolved through one or more processes. All CME content in this activity has been independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.
 
Disclosure of Unlabeled Use
The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.
 
Disclaimer
This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, University of Kentucky or Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
 
If included, signed statements of informed consent granting permission for use have been obtained for all photographs and videos in which an individual can be identified.
 
As an ACCME-accredited provider, University of Kentucky and Paradigm Medical Communications, LLC, activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by University of Kentucky and Paradigm Medical Communications, LLC.
 
Terms of Use and Privacy Policy
Disclaimer
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the faculty, and do not necessarily represent those of University of Kentucky and Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by University of Kentucky or Paradigm Medical Communications, LLC. University of Kentucky and Paradigm Medical Communications, LLC, accepts no liability for the content referenced in this activity.
 
Privacy policy
University of Kentucky and Paradigm Medical Communications, LLC, is committed to protecting the privacy of those who participate in the activities (herein referred to as “website”) located at www.paradigmmc.com. The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
 
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
 
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by University of Kentucky and Paradigm Medical Communications, LLC, to continuously improve the learning experience.
 
University of Kentucky and Paradigm Medical Communications, LLC, does not transfer, sell, or share personal information with outside parties. University of Kentucky and Paradigm Medical Communications, LLC, will not otherwise disclose personal information unless required to in a legal process. University of Kentucky and Paradigm Medical Communications, LLC, staff members review individual test results to the extent necessary to record and track participants’ credits.

Contact Us
If you have any questions or comments, please email us at contactus@paradigmmc.com.
 
©2017 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.